NRx Pharmaceuticals Completes Public Offering of Common Stock at $3.50 Per Share
NRx Pharmaceuticals (NRXP) has announced the successful closure of its underwritten public offering of common stock. The shares were offered and closed at a price of $3.50 per share. This financial transaction marks a significant development for the company in the capital markets.
NRx Pharmaceuticals, trading under the ticker symbol NRXP, has officially completed its underwritten public offering of common stock.
The offering saw shares priced at $3.50 each upon its closure. An underwritten public offering involves an investment bank or a syndicate of banks committing to purchase all shares being offered by the issuer, subsequently reselling them to the public.
According to Yahoo Finance, the completion of this offering represents a notable financial event for NRx Pharmaceuticals.
